The healthcare landscape is always evolving, but MMIT’s mission stays the same: We’re dedicated to helping clients solve their market access challenges. Learn more: https://t.co/l5XSJpwh7R

Need help driving revenue with real-world data solutions? Take it from our clients – we’ve got the expertise to help. Let’s talk. https://t.co/HAViBnyYZO

Early evidence is becoming essential for commercial success. With MMIT, teams can understand disease burden, identify high-value patients and HCPs, and pressure-test brand positioning well before launch. Schedule a meeting with us at @SCOPE_365: https://t.co/OFpe9eVuN0

https://t.co/wPX5aal05h | See the story behind the data. MMIT’s RWD Visualizations enable commercial pharma teams to quickly analyze real-world data and identify access barriers, prescribing patterns, and payer behavior. Powered by NorstellaLinQ, our unified data asset brings

Don’t trust the sauce unless you can see the ingredients. https://t.co/ELxjvB3V69 This article discusses the importance of context and transparency in AI-generated results. @panalgoinsights’s Andrew Goldstein and Niyati Parikh share tips on using AI and RWD ethically and

VIDEO: Having access to real-world data isn’t enough—you have to make sure that the data works for you. MMIT can help. Powered by NorstellaLinQ, we deliver insights when and how you need them, keeping your team focused and free from vendor back-and-forth or data wrangling. Watch

https://t.co/kRYv0r11Qz | Still relying on manual processes to validate contract positions? Contract Validation from MMIT automates the work at scale, helping manufacturers reduce rebate leakage and ensure contract accuracy across the board. See how automation delivers clarity

The introduction of private equity into the retail pharmacy space has many payers concerned, particularly about the potential for more aggressive contracting and reduced patient access. MMIT’s Jory Fleischauer, Pharm.D., shares payer commentary and discusses parallels with equity

Getting enough ROI from YOUR real-world data solutions? MMIT and NorstellaLinQ can help. Take it from our clients, and find out more here: https://t.co/cRIRmFE8dI

Tired of inconsistent plan names and messy free-text data? You’re not alone. Many teams struggle to connect the dots when datasets don’t align. That’s where MMIT’s BIN/PCN/Group data comes in — linking proprietary plan structures with real-world insights from Norstella to give

https://t.co/HaSOfq9fuU | The exponential growth of the 340B Drug Pricing Program has contributed to its many challenges, including duplicative payments. MMIT’s @AndrewRouff discusses manufacturers’ efforts to legalize a rebate model and shares provider sentiment about a

Increasing resistance rates to many common first-line antibiotics are reducing their efficacy. https://t.co/FFMI0cM3vH MMIT's Dipti Nayak weighs in on what's happening in the urology space, which will soon have three new oral antibiotics available for the treatment of

On-Demand Webinar: Identifying patients with rare diseases is just the start. In this on-demand webinar, "Uncovering New Rare Disease Patients Using Structured and Unstructured Real-World Data," our experts demonstrate how MMIT, with NorstellaLinQ, has developed a unified dataset

One Platform. One Experience. All of MMIT. ✔️ Introducing the MMIT Platform. This platform serves as a digital front door to access MMIT solutions, capabilities, and data. Gain access to everything you need, all in one place. https://t.co/owT01ssPdI

What if you could access the most comprehensive rare disease insights in one place? https://t.co/IGZE2PYXeA Our new exclusive content hub brings together expert perspectives, data-driven analysis, and stories that matter—designed for those shaping the future of rare disease

Have you experienced the MMIT Platform yet? The MMIT Platform provides a single point of entry, enabling customers to engage with solutions, data, and insights tailored to their individual needs, helping them build and execute a customized strategy. This platform serves as a

https://t.co/uPcGF1cugH | Still relying on manual processes to validate contract positions? Contract Validation from MMIT automates the work at scale, helping manufacturers reduce rebate leakage and ensure contract accuracy across the board. See how automation delivers clarity

https://t.co/Yt34Jv6AOw | From screening patterns to commercialization and physician targeting, discover how MMIT and NorstellaLinQ’s integrated structured and unstructured data can bring clarity to rare disease treatment, bringing you closer to the patient than ever before.

What are you doing to prepare for inevitable market shifts? 📈 MMIT is combining PAR Analytics and Real-World Data to provide the connected policy data and intelligence your need to stay ahead of tomorrow’s demands. Meet with us to see how. https://t.co/GfqfPJBx06

How are you making real-time market decisions to keep your brand in the prescribing tactics of HCPs? Keep your brand prescription retention up with target HCPs by gaining real-time alerts from MMIT that flag when patient triggers occur. https://t.co/UndRluuTBo

Clinical and market access teams can’t afford to work in isolation. At #SCOPESummit, we’ll show you how integrated RWD and AI-driven analytics create a unified foundation—helping commercial and access teams influence evidence strategy early, anticipate payer needs, and accelerate